These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 643908

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
    Fuxe K, Fredholm BB, Ogren SO, Agnati LF, Hökfelt T, Gustafsson JA.
    Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic drugs and ovulation: studies on PMS-induced ovulation and changes in median eminence DA and NE turnover in immature female rats.
    Agnati L, Fuxe K, Löfstöm A, Hökfelt T.
    Adv Biochem Psychopharmacol; 1977 Jun; 16():159-68. PubMed ID: 883540
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
    Miller R, Horn A, Iversen L, Pinder R.
    Nature; 1974 Jul 19; 250(463):238-41. PubMed ID: 4368645
    [No Abstract] [Full Text] [Related]

  • 10. Possible involvement of the central dopaminergic system in the antireserpine effect of LSD.
    Menon MK, Clark WG, Masuoka DT.
    Psychopharmacology (Berl); 1977 May 09; 52(3):291-7. PubMed ID: 406633
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The contrasting actions of TRH and cycloheximide in altering the effects of centrally acting drugs: evidence for the non-involvement of dopamine sensitive adenylate cyclase.
    Green AR, Heal DJ, Grahame-Smith DG, Kelly PH.
    Neuropharmacology; 1976 Oct 09; 15(10):591-9. PubMed ID: 825788
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Neuropharmacology of apomorphine (review of the literature)].
    Zharkovskiĭ AM, Allikmets LKh.
    Farmakol Toksikol; 1981 Oct 09; 44(2):226-32. PubMed ID: 7023969
    [No Abstract] [Full Text] [Related]

  • 18. Is the dopamine sensitive adenylate cyclase in the rat substantia nigra coupled with 'autoreceptors'?
    Premont J, Thierry AM, Tassin JP, Glowinski J, Blanc G, Bockaert J.
    FEBS Lett; 1976 Sep 15; 68(1):99-104. PubMed ID: 964385
    [No Abstract] [Full Text] [Related]

  • 19. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
    Oelssner W.
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982 Sep 15; 50():53-60. PubMed ID: 7157125
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.